Endothelial injury and increased vascular reactivity are involved in the pathogenesis of pre-eclampsia (pregnancy-induced hypertension). To investigate whether flow-mediated dilation (endothelium-dependent dilation) and the reactive hyperemic response can predict preeclampsia, we prospectively measured flow-mediated dilation and the Doppler flow velocity pattern (V, cm/s) in the brachial artery using high-resolution ultrasound in 43 pregnant women (32 7 5 years old) in the second half of their pregnancy, and compared the findings with traditional risk factors. Regarding the Doppler flow velocity pattern, the pulsatility index (PI) ¼ (systolic VÀdiastolic V)/mean V and resistance index (RI) ¼ (systolic VÀdiastolic V)/systolic V were calculated. For the flow-mediated dilation, the per cent diameter changes were determined based on those from baseline to hyperemic conditions. Nine women suffered from preeclampsia and 34 women remained normotensive. Only flow-mediated dilation was found to be significantly lower in the subsequently developed pre-eclampsia patients (1.6 7 1.0% in subsequently developed preeclampsia patients vs 11.0 7 4.5% in normotensive patients, Po0.05). Neither the other traditional factors nor the Doppler flow velocity pattern were significantly different between the subsequently developed preeclampsia and normotensive patients. If a normal cutoff value of 3.0% obtained from age-matched 14 nonpregnant women (32 7 7 years old) in our laboratory was used, the positive predictive value of flow-mediated dilation (o3.0%) for subsequent pre-eclampsia is 90% and the negative predictive value is 100%. In conclusion, flow-mediated dilation in brachial artery can be a simple and noninvasive modality to predict pre-eclampsia.
Introduction
Perinatal deaths are attributable to pregnancy-induced hypertension including pre-eclampsia. Both endothelial injury and increased vascular reactivity have been reported to be involved in the pathogenesis of pre-eclampsia. 1, 2 However, whether these observations in vascular activity are the result or the cause of pre-eclampsia is still not fully understood. Recently, an abnormal pattern of the brachial artery blood flow velocity after either isometric exercise or forearm ischaemia has been shown to be highly predictive of pre-eclampsia early in pregnancy. 3 From a methodological point of view, flow-mediated dilation in the brachial artery is now a widely accepted method for evaluating the endothelial function in various settings. 4, 5 In earlier reports, the flow-mediated dilation in the brachial artery was not used for the prediction of pre-eclampsia; however, it is considered to actually be more relevant to the endothelial function than blood flow measurement alone. The purpose of this study is thus to investigate whether or not flow-mediated dilation (endothelium-dependent vasodilation) can accurately predict the occurrence of pre-eclampsia, and to also compare its predictive value with either reactive hyperemic responses in the brachial artery or traditional risk factors. We prospectively measured both the flow-mediated dilation and Doppler flow velocity pattern in the brachial artery using highresolution ultrasound in pregnant women in the second half of their pregnancy in relatively high-risk patients for pre-eclampsia.
Methods

Study population
The study population consisted of 43 normotensive pregnant women (mean age 3275 years), who had been referred to the National Defense Medical College Hospital because of relatively high-risk patients for pre-eclampsia. Owing to either the presence of any clinical risk factors or an empirical decision made by a practicing obstetrician, these patients have been referred to our hospital which is the tertiary medical centre. The patients were asked to participate in this study during routine prenatal visits. They were enrolled in this study protocol during the second half of their pregnancy after their written informed consent. None of the 43 patients had any medical problems nor were they hypertensive, and none of them were taking any medications at the time they were enrolled into the study. However, seven out of 43 patients were current smokers. Regarding the control subjects, 14 healthy women (mean age 3277 years) were studied who were matched with the pregnant women by age, and the study was performed during the menstruation in their menstrual cycle. They had no coronary risk factors or family history of premature vascular disease. Informed consent was also obtained from normal subjects.
Brachial artery flow-mediated dilation study
A brachial artery function study was performed according to the previously reported methods. 6 Briefly, all studies were performed in a temperature-controlled room (251C), with the subject in a fasting, resting, and supine or right lateral decubitus position. The study was performed at around ten to eleven o'clock in the morning. Regarding the brachial artery flow-mediated dilation study, the brachial artery diameter was imaged using a 7.5 MHz linear transducer ultrasound system using a YHP Sonos 2000 (Hewlett Packard, SONOS 2000, Andover, MA, USA). The resting blood pressure measurements were performed from the left arm by Korotkoff's method. After baseline measurements were recorded, a blood pressure cuff was inflated until reaching occlusive pressure (systolic blood pressure+30 mmHg) on the most proximal portion of the forearm for 5 min in order to induce reactive hyperaemia. At 1 min after reactive hyperemia was achieved, the brachial artery diameter was again imaged to measure the diameter. To calculate flowmediated dilation, the per cent diameter changes were determined as follows: (diameter after reactive hyperemiaÀbaseline diameter)/baseline diameter Â 100. The diameter of the brachial artery was measured using a commercialized quantitative coronary angiography analysis computer (Kontron Elektronik, Cardio 500, Munich, Germany). Regarding the brachial artery, images at peak systole when a maximal dilation of brachial artery occurs were identified and the diameter was digitized. The average diameter values of three cardiac cycles were thus obtained. The mean diameter of the brachial artery was determined at baseline and at 1 min after reactive hyperemia. The brachial artery diameter analysis was performed in a blind manner regarding the patient and control backgrounds. In order to assess the repeatability of the flow-mediated dilation, 14 healthy women underwent brachial artery flow-mediated dilation study twice a day.
Brachial artery blood flow velocity analysis
All measurements were also taken according to previously reported methods. 3 For the analysis of the flow velocity responses in the brachial artery to reactive hyperemia, the Doppler flow pattern was analysed using the same ultrasound system as the flow-mediated dilation. The flow velocity was calculated by the velocity-time integral of the Doppler flow signal (corrected for angle) by the heart rate using public domain software (Hewlett Packard, SONOS 2000) at rest and during reactive hyperemia. The flow velocity was taken from the centre of the brachial artery. The Doppler flow patterns were analysed at rest and during reactive hyperemia caused by the same method as flowmediated dilation. The Doppler flow pattern of an increased blood flow at reactive hyperemia was recorded in the first 15 s after cuff deflation. The Doppler wave forms of three cardiac cycles were recorded and analysed according to the following methods; from the Doppler wave forms, the systolic velocity (V s ), diastolic velocity (V d ) and mean velocity (mean V) were all measured. In addition, the pulsatility index (PI) and resistance index (RI) were obtained according to the following formulas:
Traditional risk factors analysis
We interviewed the pregnant women regarding the traditional risk factors for pre-eclampsia. These risk factors include (1) the presence of a primigravid status, (2) a past history and family history of pre-eclampsia, hypertension, diabetics, premature vascular disease, autoimmune or renal disorders, (3) a history of smoking, (4) an age of over 35 years and (5) the presence of multiple gestations. The above traditional risk factors were analysed in a dichotomous fashion according to the presence or absence of each risk factor.
Biochemical analysis
Venous blood (10 ml) was withdrawn from the antecubital vein about 1 h before the brachial artery flow-mediated dilation study and a blood flow velocity analysis under overnight fasting conditions. The serum levels of total cholesterol, HDL cholesterol, triglyceride and glucose were measured. In addition, the plasma levels of endothelin-1 and asymmetric dimethyl arginine (ADMA) were simultaneously measured by the previously described methods 7, 8 including radioimmunoassay and highperformance liquid chromatography, respectively. 
Follow-up of the patients
No patients were followed up by the authors. In addition, no authors were directly involved in the management of the study patients. The results of both the brachial artery flow-mediated dilation and a blood flow velocity analysis were not made available to the managing physicians, and also were not given to participating patients. As a result, these findings did not influence the management of the patients studied. A follow-up to term was made and the medical records were reviewed for each patient to determine the presence or absence of preeclampsia. Pre-eclampsia was defined as follows:
(1) Normotension before 20 weeks' gestation (before and at the enrolment of the study), and hypertension and proteinuria subsequently developed. (2) Hypertension and proteinuria were diagnosed when patients had a blood pressure greater than or equal to 140/90 mmHg or a relative increase in systolic presume of 30 mmHg over the blood pressure at the enrolment of the study, and significant proteinuria (2+ on a clean catch or greater than or equal to 300 mg/24 h). In addition, the presence of hypertension was carefully confirmed by a single diastolic blood pressure of 4100 mmHg or a consecutive reading of 490 mmHg on more than one occasion, at least 4 h apart, according to the criteria proposed by the American College of Obstetricians and Gynecologists' report. 9 Blood pressure measures were obtained by Korotkoff's method and the mean values of three consecutive measurements were used to determine a baseline and a follow-up blood pressure. The level of proteinuria in this study was assessed by a qualitative method. Negative for proteinuria correlates with o8 mg/dl and 2+ with 4300 mg/dl in our laboratory.
Statistical analysis and term used in test accuracy
All data were expressed as the mean7s.d. Student's t-test was used for comparisons between the two groups. ANOVA was used for comparisons among the three groups, and subsequent alpha levels were corrected using the Scheffe method. Frequency distributions were compared using the w 2 test or Fisher's exact test. To examine the repeatability of brachial artery flow-mediated dilation, we used the method proposed by Bland and Altman. 10 Differences were considered significant if Po0.05. Test accuracy was defined based on the same methodology and criteria as that used in exercise testing.
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True-positive (TP) was defined as abnormal test results in individuals with disease (pre-eclampsia); false-positive (FP) as abnormal test results in individuals without disease (pre-eclampsia); truenegative (TN) as normal test results in individuals without disease (pre-eclampsia); false-negative (FN) as normal test results in individuals with disease (pre-eclampsia). According to these parameters, the positive predictive value for disease (pre-eclampsia) was calculated according to the formula of TP/ (TP+FP) and the negative predictive value for disease (pre-eclampsia) as the formula of TN/ (TN+FN).
Results
Clinical characteristics and demographic data
Until at the time of delivery, 34 of the 43 patients remained normotensive throughout the pregnancy. Nine of the 43 patients subsequently suffered from pre-eclampsia. The selected clinical characteristics among the normotensive patients, the subsequently developed pre-eclampsia (hypertensive) patients and nonpregnant women are listed in Table 1 . The mean ages were not different among the three groups. The gestational weeks at the time of the study and delivery weeks were not different. The mean gestational age at enrolment was 2974 weeks for the normotensive patients and 2975 weeks for the subsequently developed pre-eclampsia patients. The blood pressures at enrolment into the study were also not different between the normotensive and the subsequently developed pre-eclampsia patients, and these values were also not different from those in the nonpregnant women in this study. Diastolic blood pressure in the normotensive Flow-mediated dilation and preeclampsia B Takase et al patients was significantly lower than that of nonpregnant women. About the level of proteinuria, all patients were negative at enrolment. However, the subsequently developed pre-eclampsia patients had a significantly higher blood pressure at the onset of pre-eclampsia by definition, and their level of proteinuria was greater than 2+ correlated with 4300 mg/dl. The gestational age at delivery was also not significantly different. The gestational age at delivery was 3972 weeks for the normotensive patients and 3871 weeks for the subsequently developed pre-eclampsia patients. Regarding the incidence of a caesarean delivery, there were no significant differences between the normotensive and the subsequently developed pre-eclampsia patients. The average birth weight for the normotensive patients was 32817224 g, while that of the subsequently developed pre-eclampsia patients was 32907190 g (P ¼ NS).
Brachial artery flow-mediated dilation study and flow velocity analysis (Table 2 ) Figure 1 illustrates the image findings of the brachial artery diameters in typical cases. Flow-mediated dilation was impaired significantly more in the subsequently developed pre-eclampsia patients than in the normotensive patients and nonpregnant women ( Table 2 and Figure 2 ). Among 43 patients, 12 patients had a past history of pre-eclampsia while 31 patients did not. Flow-mediated dilation was significantly lower in patients with a past history of pre-eclampsia than in patients without a history of pre-eclampsia (6.573.1 vs 10.075.9%, Po0.05). Also, flow-mediated dilation was significantly greater in the normotensive patients than in nonpregnant women ( Table 2 ). The vessel diameters were not significantly different among the normotensive, the subsequently developed pre-eclampsia patients and nonpregnant women in the present study. In contrast to flow-mediated dilation, neither pulsatility nor resistance indices were significantly different at baseline or during reactive hyperemia. Both indices significantly and similarly decreased due to reactive hyperemia. Since the values of flow-mediated dilation in nonpregnant women ranged from 3.0 to 15.0%, and none of them had any flow-mediated dilation o3.0% (Figure 2) , we set the normal cutoff value of flow-mediated dilation at X3.0%. None of the subsequently developed pre-eclampsia patients had any flow-mediated dilation X3.0%, while only one patient had flow-mediated dilation o3.0% in the normotensive patients. This patient had a past history of pre-eclampsia. In addition, the flowmediated dilator response measurements were repeated twice a day in nonpregnant women and the repeatabilities obtained from these measurements were found to be acceptable (variability o2.0%, Figure 3 ). When we take X3.0% as a normal cutoff value for flow-mediated dilation in the brachial artery, this predictive value (flow-mediated dilation o3.0%) for subsequent suffering pre-eclampsia was calculated to be 90% of a positive predictive value Flow-mediated dilation and preeclampsia B Takase et al and 100% of a negative predictive value, respectively. This calculation was made based on the formula provided in the methods section.
Traditional risk factors, serum lipids levels and antiendothelium substances
Comparisons about traditional risk factors between the normotensive and the subsequently developed pre-eclampsia patients are shown in Table 3 . The number of primigravid patients, the percentage of patients with a past history of pre-eclampsia and the prevalence of a high maternal age (435 years old) were almost identical between the normotensive and pre-eclampsia patients. The other traditional risk factors were also not significantly different between the normotensive and the subsequently developed pre-eclampsia patients. Although the serum levels of total cholesterol and triglyceride were slightly higher in the subsequently developed pre-eclampsia patients than in the normotensive patients, these differences were not significant. The serum levels of total cholesterol, HDL cholesterol and triglyceride were significantly elevated in both the normotensive and pre-eclampsia patients compared with the nonpregnant women. As for endothelin-1 and ADMA, the plasma levels of endothelin-1 in the subsequently developed preeclampsia patients were slightly higher than those in the normotensive patients, although the differences were not significant. No differences were seen in the ADMA levels.
Discussion
The present study demonstrated that flow-mediated dilation in the brachial artery measured during the second half of pregnancy can predict the subsequent development of pre-eclampsia in relatively high-risk patients for pre-eclampsia, while both the reactive hyperemic flow responses in the brachial artery and the traditional risk factors were not substantially different between the pregnant women who remained normotensive and those who subsequently developed pre-eclampsia. The incidence of preeclampsia in the average antenatal population is in the order of 3-5%. 12 In this study, 21% of the patients developed pre-eclampsia. As 12/43 patients had a history of pre-eclampsia, three patients had a family history of pre-eclampsia and two patients had previous renal dysfunction, the group was Flow-mediated dilation and preeclampsia B Takase et al considered to be a relatively high-risk population. This happened because our hospital is a tertiary medical centre. Several factors have been reported that impair flow-mediated dilation in the brachial artery. Among them, hypertension, diabetics, smoking, hypercholesterolemia and a family history of premature vascular diseases are included. In addition, the vessel diameter is also reported to significantly influence flow-mediated dilation. 6 In the present study, the factors influencing flow-mediated dilation, which include the brachial vessel diameters, were identical not only in the normotensive patients and pre-eclampsia patients but also in the nonpregnant women. The plasma cholesterol levels also play an important role in the flow-mediated dilation. Although the serum lipids levels were significantly higher in the normotensive and preeclampsia patients than those in the nonpregnant women, these lipid levels were not different between the normotensive and pre-eclampsia patients. We determined the normal cutoff value to be X3.0% in flow-mediated dilation in the nonpregnant women who were age matched and did not have any risk factors that impair flow-mediated dilation. Since the menstrual cycle affects flowmediated dilation in the brachial artery, 13 we measured flow-mediated dilation during the menstruation in control nonpregnant women. As a result, the value of flow-mediated dilation in the nonpregnant women in this study is considered to be the normal range in our laboratory for young women. When we used the cutoff value of o3.0% in flow-mediated dilation to predict pre-eclampsia, the calculated positive prediction values and negative predictive values were high enough for clinical use, and good enough for flow-mediated dilation to be a useful test.
The reason why flow-mediated dilation in the brachial artery is impaired before the clinical findings of pre-eclampsia become overt was not clarified from this study. Since a decreased nitric oxide and impaired vascular endothelial function can reflect the lower flow-mediated dilation in brachial artery, impaired flow-mediated dilation suggests that the vascular endothelial dysfunction exists. Several clinical studies have been conducted to investigate the role of the endothelium in the pathogenesis of pre-eclampsia. Some studies have shown a decreased nitric oxide production in preeclampsia whereas other studies have shown conflicting results. [14] [15] [16] Cockell et al 17 reported flowmediated dilation in the subcutaneous artery to be impaired in pre-eclampsia, thus suggesting the existence of endothelial dysfunction in pre-eclampsia. The earlier report 18 has suggested that an abnormality in the resistance-artery endothelium may be present in patients with pre-eclampsia. In addition, Yosida et al 19 reported that flow-mediated dilation decreases in patients with pre-eclampsia. These reports support the fact that endothelial dysfunction is thus involved in the pathogenesis of pre-eclampsia. We therefore speculate that endothelial dysfunction could possibly antedate the clinical appearance of pre-eclampsia.
It remains to be clarified as to whether the changes in vasoreactivity in pre-eclampsia are mainly due to the intrinsic dysfunction in the vessel or due to the secondary effect of circulatory factors that originate in the placenta of pre-eclampsia patients. Although there has still been no definitive study showing a decreased nitric oxide production in pre-eclampsia patients, 20 an earlier report 21 did show the plasma levels of endothelin-1 and prostaglandin E 2 to increase in patients with pre-eclampsia, and these substances are known to impair the endothelial function. In another report, 22 pre-eclampsia patients were also shown to have increased plasma levels of oxidized small dense low-density lipoprotein that can impair the endothelial function. There have also been several reports showing the presence of increased oxidative stress in pre-eclampsia patients. 23 Another interesting report 24 showed increased plasma levels of asymmetric dimethyl arginine (ADMA) and N G -methyl-L-arginine(L-NMMA) in pre-eclampsia patients. These substances antagonize endothelial function. In this study, however, the endothelin-1 in the subsequently developed pre-eclampsia patients was not significantly different from that in the normotensive patients, and there were also no differences in the ADMA levels. Different from previous reports, these measurements were performed before the onset of clinically overt pre-eclampsia. The plasma levels of endothelin-1 and ADMA were not predictive for subsequent development of pre-eclampsia. In addition, Chamber et al 25 reported that impaired flowmediated dilation in brachial artery is observed in nonpregnant women with remote prior pre-eclampsia. They suggest that the maternal endothelial dysfunction might underlie the pathophysiology of pre-eclampsia. In this study, we observed lower flow-mediated dilation in patients with a past history of pre-eclampsia compared with those without prior pre-eclampsia. This finding is in agreement with the previous report. 25 Recent reports also show that normal pregnancy enhances flowmediated dilation in brachial artery with conflicting results on resting vessel diameters. 26, 27 Our results agree with these findings; flow-mediated dilation in normotensive patients was significantly greater than that in nonpregnant women, whereas flow-mediated dilation in the subsequently developed pre-eclampsia patients was impaired (Table 2 ). We thus speculate that some intrinsic dysfunction might play an important role in the changes in vasoreactivity in pre-eclampsia. It is suggested that decreased flow-mediated dilation is one of the important maternal mechanisms underlying preeclampsia and flow-mediated dilation should be evaluated for predicting subsequent development of pre-eclampsia.
Since earlier studies on abnormal vasoactivity were mostly conducted in the patients with preeclampsia, whether or not changes in vasoactivity are the result or the cause of pre-eclampsia has yet to be elucidated. The present study showed a decreased flow-mediated dilation in the brachial artery in the second half of pregnancy in some normotensive pregnant women at the enrolment of the study. These results suggest that an abnormal vasoactivity might be the cause of pre-eclampsia. Veille et al 3 and Tomoda et al 28 reported the Doppler flow velocity pattern during either reactive hyperemia or handgrip exercise to be predictive of pre-eclampsia. In contrast, our results showed the Doppler flow velocity pattern not to be predictive. This discordance may be due to differences in the study methodology between our study and earlier ones. Since Celermajer et al 5 first reported the method of flow-mediated dilation in the brachial artery, this method of flow-mediated dilation has become widely accepted as a noninvasive method for evaluating the endothelial function in various clinical settings. This method is simple and noninvasive and can be completed within 20 min, if nitroglycerin is not administrated.
Since the number of patients was small, traditional risk factors may not play a role in predicting pre-eclampsia. These risk factors have been mostly determined based on epidemiological studies. 29, 30 In addition, the patients with pre-eclampsia in our study only showed a mild form even if they were relatively high-risk patients. This might be another reason why traditional risk factors did not work.
The study limitations are the following. First, since we did not administrate nitroglycerin in the brachial artery flow-mediated dilation study, it is uncertain whether the impaired flow-mediated dilation is due to reduced endothelial nitric oxide or results of inability of the vascular smooth muscle to respond to nitric oxide. In addition, no postpartum studies were performed so that we did not determine whether the impaired flow-mediated dilation in patients who subsequently developed pre-eclampsia is specific to pregnancy or the underlying condition reported by Chambers et al. 25 However, even if the mechanism of lower flowmediated dilation in pregnant women in this study is unclear, flow-mediated dilation in the brachial artery could be useful as a clinical tool for predicting pre-eclampsia because this test is simple, not time consuming and a noninvasive method. Second, the predictive power of flow-mediated dilation for preeclampsia should be carefully considered because of the small number of pre-eclampsia events, and the small numbers of patients studied. Especially, in order to exclude a false positive in terms of flowmediated dilation for predicting pre-eclampsia, this study should be duplicated in the larger cohort in the near future.
Our results support the hypothesis that pregnant women who subsequently suffer from pre-eclampsia have an impaired flow-mediated dilation in the brachial artery at the beginning of the second half of pregnancy. As a result, flow-mediated dilation in the brachial artery might become a simple and noninvasive modality for predicting pre-eclampsia.
This study was presented in part at the 73rd annual meeting of the American Heart Association held in New Orleans in November 2000.
